Pyxis Tankers Equity Warrant Exp 19th Aug 2025 *W EXP 08/19/2025
Change company Symbol lookup
Select an option...
PXSAW Pyxis Tankers Equity Warrant Exp 19th Aug 2025 *W EXP 08/19/2025
TAP Molson Coors Beverage Co
CLS Celestica Inc
TWOU 2U Inc
CGTX Cognition Therapeutics Inc
BHAT Blue Hat Interactive Entertainment Technology
DBTX Decibel Therapeutics Inc
CLSK CleanSpark Inc
AER AerCap Holdings NV
AOD Aberdeen Total Dynamic Dividend Fund
Go

Industrials : Marine | Small Cap Value
Based in Greece
Company profile

Pyxis Tankers Inc. is a maritime transportation holding company. The Company is focused on the product tanker sector. It owns a fleet of six double hull product tankers: Pyxis Epsilon with carrying capacity of approximately 50,295 deadweight tonnage (dwt); Pyxis Theta with carrying capacity of approximately 51,795 dwt, Pyxis Malou with carrying capacity of over 50,667 dwt; Pyxis Delta with carrying capacity of approximately 46,616 dwt; Northsea Beta with carrying capacity of over 8,647 dwt, and Northsea Alpha with carrying capacity of approximately 8,615 dwt. Four of the Company's vessels in the fleet are medium-range (MR), product tankers, three have eco-efficient or eco-modified designs, and two of them are short-range tanker sister ships. Its fleet is capable of transporting refined petroleum products, such as naphtha, gasoline, jet fuel, kerosene, diesel and fuel oil, as well as other liquid bulk items, such as vegetable oils and organic chemicals.

Closing Price
$0.3524
Day's Change
0.00 (0.00%)
Bid
--
Ask
--
B/A Size
--
Day's High
--
Day's Low
--
Volume
(Light)
Volume:
0

10-day average volume:
6,970
0

IBM, ABBV, & TWTR Class Actions: Bronstein, Gewirtz & Grossman, LLC, A Leading Class Action Firm Reminds Shareholders to Actively Participate

11:00 am ET May 16, 2022 (Accesswire) Print

NEW YORK, NY / ACCESSWIRE / May 16, 2022 / Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against the following publicly-traded companies. You can review a copy of the Complaints by visiting the links below or you may contact Peretz Bronstein, Esq. or his Investor Relations Analyst, Yael Nathanson of Bronstein, Gewirtz & Grossman, LLC at 212-697-6484. If you suffered a loss, you can request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff. A lead plaintiff acts on behalf of all other class members in directing the litigation. The lead plaintiff can select a law firm of its choice. An investor's ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

Bronstein, Gewirtz and Grossman, LLC, Monday, May 16, 2022, Press release picture

International Business Machines Corporation (NYSE:IBM)

Class Period: April 4, 2017 - October 20, 2021

Deadline: June 6, 2022

For more info: www.bgandg.com/ibm.

The Complaint alleges that the Defendants made materially false and misleading statements and/or omitted to disclose that: (1) Strategic Imperatives Revenue and growth, CAMS and CAMS Components' revenue and growth, and the Company's Segments' revenue and growth were artificially inflated as a result of the wrongful reclassification of revenues from non-strategic to strategic to make those revenues eligible for treatment as Strategic Imperatives Revenue; (2) the Company's present success and positive future growth prospects concerning its Strategic Imperative business strategy were being fueled by the wrongful reclassification of revenues from non-strategic to strategic to make those revenues eligible for treatment as Strategic Imperative Revenue and, as a result (3) misled the market by portraying the Company's Strategic Imperative's financial performance and future prospects more favorable than they actually were as a result of the fraudulent scheme and/or the wrongful reclassification of revenues from non-strategic to strategic to make those revenues eligible for treatment as Strategic Imperatives.

AbbVie, Inc. (NYSE:ABBV)

Class Period: April 30, 2021 - August 31, 2021

Deadline: June 6, 2022

For more info: www.bgandg.com/abbv

The complaint alleges that, throughout the Class Period, the Defendants made materially false and/or misleading statements, about the company's business and operations. Specifically, Defendants misrepresented and/or failed to disclose that: (1) safety concerns about Xeljanz extended to Rinvoq and other JAK inhibitors; (2) as a result, it was likely that the FDA would require additional safety warnings for Rinvoq and would delay the approval of additional treatment indications for Rinvoq; and (3) therefore, Defendants' statements about the company's business, operations, and prospects lacked a reasonable basis, As a result of the Defendants' wrongful acts and omissions, and the significant decline in the market value of AbbVie's securities, AbbVie investors have suffered significant damages.

Twitter, Inc. (NYSE:TWTR)

Class Period: March 24, 2022 - April 1, 2022

Deadline: June 13, 2022

For more info: www.bgandg.com/twtr.

On April 4, 2022, Elon Musk announced that he had purchased over 73 million shares of Twitter stock - a 9.2% stake in the Twitter. Following this news, Twitter stock surged on April 4, 2022, closing 27% higher than its closing price the previous day. The complaint alleges that by failing to timely disclose his ownership stake, Musk was able to acquire shares of Twitter less expensively during the Class Period.

Contact:

Bronstein, Gewirtz & Grossman, LLC

Peretz Bronstein or Yael Nathanson

212-697-6484 | info@bgandg.com

SOURCE: Bronstein, Gewirtz & Grossman, LLC





View source version on accesswire.com:

https://www.accesswire.com/699705/IBM-ABBV-TWTR-Class-Actions-Bronstein-Gewirtz-Grossman-LLC-A-Leading-Class-Action-Firm-Reminds-Shareholders-to-Actively-Participate



comtex tracking

COMTEX_407271036/2457/2022-05-16T11:00:38

Earnings Calendar and Events Data provided by |Terms of Use| © 2022 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2022. All rights reserved.